The use of genetically engineered cells for assessing CYP2D6-related polymorphic effects

Author： Coecke S.   Bogni A.   Langezaal I.   Worth A.   Hartung T.   Monshouwer M.  

Publisher： Elsevier

ISSN： 0887-2333

Source： Toxicology in Vitro, Vol.15, Iss.4, 2001-08, pp. : 553-556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Embryotoxic Chemicals on the In vitro Differentiation of Genetically Engineered Embryonic Stem Cells into Cardiac Cells

By Bremer S.   van Dooren M.   Paparella M.   Kossolov E.   Fleischmann B.K.   Hescheler J.  

Toxicology in Vitro, Vol. 13, Iss. 4, 1999-08 ,pp. : 645-650

Elsevier

Access to resources Recommend Favorite

ESA Participation in Issues Related to Genetically Engineered Organisms

By  

The Bulletin of the Ecological Society of America, Vol. 68, Iss. 1, 1987-03 ,pp. : 15-16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enantioselective Analysis of Citalopram and Escitalopram in Postmortem Blood Together with Genotyping for CYP2D6 and CYP2C19

By Carlsson Björn  

Journal of Analytical Toxicology, Vol. 33, Iss. 2, 2009-03 ,pp. : 65-76

Oxford University Press

Access to resources Recommend Favorite

Enantioselective Analysis of Citalopram and its Metabolites in Postmortem Blood and Genotyping For CYD2D6 and CYP2C19

By Holmgren Per  

Journal of Analytical Toxicology, Vol. 28, Iss. 2, 2004-03 ,pp. : 94-104

Oxford University Press

Access to resources Recommend Favorite

SHORT COMMUNICATION: CYP2D6 Ultrarapid Metabolism and Morphine/Codeine Ratios in Blood: Was it Codeine or Heroin?

By He Y.J.  

Journal of Analytical Toxicology, Vol. 32, Iss. 2, 2008-03 ,pp. : 178-182

Oxford University Press

Access to resources Recommend Favorite